6533b861fe1ef96bd12c57d9

RESEARCH PRODUCT

Incidence of liver retransplantation and its effect on patient survival.

Omar S. OmarIoannis FouzasSilvio NadalinGeorgios C. SotiropoulosGeorge SgourakisM. MalagóC. E. BroelschHauke LangArnold RadtkeSusanne BeckebaumG. GerkenErnesto P. MolmentiAndreas PaulFuat H. Saner

subject

AdultMaleReoperationmedicine.medical_specialtyAdolescentYoung AdultOverall survivalMedicineHumansSurvivorsAgedRetrospective StudiesTransplantationDeceased donorbusiness.industryIncidence (epidemiology)Patient SelectionPatient survivalHepatitis CMiddle Agedmedicine.diseaseSurgeryLiver TransplantationTransplantationSurvival RateHepatic artery thrombosissurgical procedures operativeMedian timeSurgeryFemalebusiness

description

Purpose. The purpose of this study was to review our institutional experience with re-liver transplantation (OLT) after split and full-size OLT. Patients and methods. We evaluated data corresponding to retransplanted patients over an 8-year period who underwent deceased donor OLT at our institution. Variables analyzed included indications for primary OLT, and re-OLT, the type of graft used during the initial versus re-OLT, the time from initial to re-OLT, and patient survival after re-OLT. Results. Sixty-four of 697 first OLT (9.2%) required re-OLT. Forty-nine cases were among 637 (7.6%) full-size OLT, while 15 were among 60 (25%) split OLT (P <.001). Median time to re-OLT was 8 days (range = 1-1885 days). Main indications for re-OLT were primary nonfunction/initial poor function (44%), hepatic artery thrombosis (26%), biliary complications (11%), and hepatitis C recurrence (6%). Forty-eight percent of the re-OLTs were performed within the first posttransplant week. The overall survival for these 64 patients was 55% and 48% at 1 and 3 years after the primary OLT, and 44% at both 1 and 3 years after the re-OLT, respectively. Conclusions. The overall incidence of re-OLT remains 9%. Approximately half of all re-OLT occured within the first posttransplant week. Early retransplantation was associated with the best patient survival. Overall survival after re-OLT was about 10% to 20% lower than that after primary OLT.

10.1016/j.transproceed.2008.09.039https://pubmed.ncbi.nlm.nih.gov/19010234